Budesonide Respules (Pulmicort) inhalation suspension: AstraZeneca sued Apotex to seek a declaration of patent infringement

In continuation of our earlier post on Budesonide Here, Innovator Astra announced ( in a press release Here) that Astra has filed a lawsuit in the US District Court for the District of New Jersey against Apotex (Apotex) seeking a declaration of patent infringement
Also, Innovator has filed a motion for Interim Relief seeking to prohibit sales of Apotex’s generic product until the patent infringement case has concluded. The Court has indicated that it will hear oral arguments regarding the motion on 16 April 2009.